Effects of hydralazine on the pulmonary vasculature and respiratory control in humans

Experimental Physiology

Volumn 93, Issue 1, 2008, Pages 104-114

  Liu, Chun ^a   Balanos, George M ^b   Fatemian, Marzieh ^a   Smith, Thomas G ^a   Dorrington, Keith L ^a   Robbins, Peter A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GENE PRODUCT; HYDRALAZINE; HYPOXIA INDUCIBLE FACTOR 1; PLACEBO; VASCULOTROPIN;

ADULT; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; GENE CONTROL; GENE EXPRESSION; HEART OUTPUT; HEART RATE; HUMAN; HYPOXIA; LUNG BLOOD VESSEL; LUNG VENTILATION; MALE; PROTEIN BLOOD LEVEL; RESPIRATION CONTROL; SYSTOLIC BLOOD PRESSURE; TRICUSPID VALVE; VOLUNTEER;

EID: 37349046340     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2007.039750     Document Type: Article

References (42)

1. Allemann Y, Sartori C, Lepori M, Pierre S, Melot C, Naeije R, Scherrer U & Maggiorini M (2000). Echocardiographic and invasive measurements of pulmonary artery pressure correlate closely at high altitude. Am J Physiol Heart Circ Physiol 279, H2013 H2016.
2. Ang SO, Chen H, Hirota K, Gordeuk VR, Jelinek J, Guan Y, Liu E, Sergueeva AI, Miasnikova GY, Mole D, Maxwell PH, Stockton DW, Semenza GL & Prchal JT (2002). Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet 32, 614 621.
3. Balanos GM, Talbot NP, Dorrington KL & Robbins PA (2003). Human pulmonary vascular response to 4 h of hypercapnia and hypocapnia measured using Doppler echocardiography. J Appl Physiol 94, 1543 1551.
4. Balanos GM, Talbot NP, Robbins PA & Dorrington KL (2005). Separating the direct effect of hypoxia from the indirect effect of changes in cardiac output on the maximum pressure difference across the tricuspid valve in healthy humans. Pflugers Arch 450, 372 380.
5. + channels. Eur J Pharmacol 361, 43 49.
6. Chan KL, Currie PJ, Seward JB, Hagler DJ, Mair DD & Tajik AJ (1987). Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure. J Am Coll Cardiol 9, 549 554.
7. Corriveau ML, Rosen BJ, Keller CA, Chun DS & Dolan GF (1988). Effect of posture, hydralazine, and nifedipine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 138, 1494 1498.
8. Corriveau ML, Shepard JW Jr. & Dolan GF (1987). Effects of hydralazine on mouth occlusion pressure and ventilatory response to hypercapnia in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am Rev Respir Dis 135, 118 122.
9. Eckardt KU, Boutellier U, Kurtz A, Schopen M, Koller EA & Bauer C (1989). Rate of erythropoietin formation in humans in response to acute hypobaric hypoxia. J Appl Physiol 66, 1785 1788.
10. Ellershaw DC & Gurney AM (2001). Mechanisms of hydralazine induced vasodilation in rabbit aorta and pulmonary artery. Br J Pharmacol 134, 621 631.
11. Ferrara N (2004). Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25, 581 611.
12. Gordeuk VR, Sergueeva AI, Miasnikova GY, Okhotin D, Voloshin Y, Choyke PL, Butman JA, Jedlickova K, Prchal JT & Polyakova LA (2004). Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood 103, 3924 3932.
13. Groves BM, Rubin LJ, Frosolono MF, Cato AE & Reeves JT (1985). A comparison of the acute hemodynamic effects of prostacyclin and hydralazine in primary pulmonary hypertension. Am Heart J 110, 1200 1204.
14. Gurney AM & Allam M (1995). Inhibition of calcium release from the sarcoplasmic reticulum of rabbit aorta by hydralazine. Br J Pharmacol 114, 238 244.
15. Hannhart B, Bertrand D, Peslin R & Bohadana A (1983). Effects of induced hypotension on breathing pattern in halothane-anaesthetized man. Eur J Clin Invest 13, 379 382.
16. Hu J, Discher DJ, Bishopric NH & Webster KA (1998). Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. Biochem Biophys Res Commun 245, 894 899.
17. Ishii M, Kato H, Inoue O, Takagi J, Akagi T, Miyake T, Sugimura T, Maeno Y, Hashino K & Kawano T (1996). Noninvasive evaluation of systolic pressures of pulmonary artery and right ventricle using contrast-enhanced Doppler echocardiography: comparative study using sonicated albumin or glucose solution. Pediatr Cardiol 17, 175 180.
18. Keller CA, Shepard JW Jr., Chun DS, Dolan GF, Vasquez P & Minh VD (1984). Effects of hydralazine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am Rev Respir Dis 130, 606 611.
19. Kline DD, Peng YJ, Manalo DJ, Semenza GL & Prabhakar NR (2002). Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α. Proc Natl Acad Sci U S A 99, 821 826.
20. Knaupp W, Khilnani S, Sherwood J, Scharf S & Steinberg H (1992). Erythropoietin response to acute normobaric hypoxia in humans. J Appl Physiol 73, 837 840.
21. Knowles HJ, Tian YM, Mole DR & Harris AL (2004). Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1α, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases. Circ Res 95, 162 169.
22. Liang PJ, Bascom DA & Robbins PA (1997). Extended models of the ventilatory response to sustained isocapnic hypoxia in humans. J Appl Physiol 82, 667 677.
23. 2 in humans. J Appl Physiol 81, 2274 2286.
24. Liu C, Smith TG, Balanos GM, Brooks J, Crosby A, Herigstad M, Dorrington KL & Robbins PA (2007). Lack of involvement of the autonomic nervous system in early ventilatory and pulmonary vascular acclimatization to hypoxia in humans. J Physiol 579, 215 225.
25. Lupi-Herrera E, Seoane M & Verdejo J (1984). Hemodynamic effect of hydralazine in advanced, stable chronic obstructive pulmonary disease with cor pulmonale. Immediate and short-term evaluation at rest and during exercise. Chest 85, 156 163.
26. +-stimulated rabbit aortic strips. J Pharmacol Exp Ther 207, 40 48.
27. Milkiewicz M, Hudlicka O, Shiner R, Egginton S & Brown MD (2006). Vascular endothelial growth factor mRNA and protein do not change in parallel during non-inflammatory skeletal muscle ischaemia in rat. J Physiol 577, 671 678.
28. Miller MJ, Chappell TR, Cook W, De Olazabal JR & Rubin LJ (1983). Effects of oral hydralazine on gas exchange in patients with cor pulmonale. Am J Med 75, 937 942.
29. + of intestinal smooth muscle by hydralazine. J Auton Pharmacol 16, 169 176.
30. Oltmanns KM, Gehring H, Rudolf S, Schultes B, Hackenberg C, Schweiger U, Born J, Fehm HL & Peters A (2006). Acute hypoxia decreases plasma VEGF concentration in healthy humans. Am J Physiol Endocrinol Metab 290, E434 E439.
31. Packer M, Greenberg B, Massie B & Dash H (1982). Deleterious effects of hydralazine in patients with pulmonary hypertension. N Engl J Med 306, 1326 1331.
32. Palmer LA, Semenza GL, Stoler MH & Johns RA (1998). Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am J Physiol Lung Cell Mol Physiol 274, L212 L219.
33. Ren X, Dorrington KL, Maxwell PH & Robbins PA (2000). Effects of desferrioxamine on serum erythropoietin and ventilatory sensitivity to hypoxia in humans. J Appl Physiol 89, 680 686.
34. Robbins PA, Swanson GD & Howson MG (1982). A prediction-correction Scheme for forcing alveolar gases along certain time courses. J Appl Physiol 52, 1353 1357.
35. Rubin SA, Brown HV & Swan HJ (1982). Arterial oxygenation and arterial oxygen transport in chronic myocardial failure at rest, during exercise and after hydralazine treatment. Circulation 66, 143 148.
36. 2 dissociation computations. J Appl Physiol 46, 599 602.
37. Shepherd AM, Ludden TM, McNay JL & Lin MS (1980). Hydralazine kinetics after single and repeated oral doses. Clin Pharmacol Ther 28, 804 811.
38. Shimoda LA, Manalo DJ, Sham JS, Semenza GL & Sylvester JT (2001). Partial HIF-1α deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia. Am J Physiol Lung Cell Mol Physiol 281, L202 L208.
39. Smith TG, Brooks JT, Balanos GM, Lappin TR, Layton DM, Leedham DL, Liu C, Maxwell PH, McMullin MF, McNamara CJ, Percy MJ, Pugh CW, Ratcliffe PJ, Talbot NP, Treacy M & Robbins PA (2006). Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology. PLoS Med 3, e290, 1178 1185.
40. Stroka DM, Burkhardt T, Desbaillets I, Wenger RH, Neil DA, Bauer C, Gassmann M & Candinas D (2001). HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 15, 2445 2453.
41. Stunkard A, Wertheimer L & Redisch W (1954). Studies on hydralazine; evidence for a peripheral site of action. J Clin Invest 33, 1047 1053.
42. Yock PG, Hatle L & Popp RL (1986). Patterns and timing of Doppler-detected intracavitary and aortic flow in hypertrophic cardiomyopathy. J Am Coll Cardiol 8, 1047 1058.